The study indicates that depression and anxiety are considerably more prevalent among adults who have survived childhood cancer. Read more: https://medicalxpress.com/news/2026-09-childhood-cancer-survivors-symptoms-anxiety.html

A study of how cells repair radiation-induced genetic damage offers clues to why some people develop cancer early in life or more than once. Read more: https://medicalxpress.com/news/2026-09-childhood-cancer-survivors-cells-dose.html

Many male survivors of childhood cancer do not think they are at increased risk for sexual dysfunction, including some who underwent gonadotoxic chemotherapy or radiation to the pelvis, according to research published in Cancer. Read more: https://www.cancertherapyadvisor.com/news/male-childhood-cancer-survivors-underestimate-sexual-dysfunction/

As more children survive cancer, doctors are shifting the focus from simply defeating the disease to protecting growth, fertility, heart health, learning and emotional well-being for decades to come. Read more: https://www.firstpost.com/health/childhood-cancer-why-surviving-the-disease-is-only-the-beginning-14045619.html

Scientists have found that certain chemotherapy drugs can age children’s healthy cells, causing the same amount of DNA damage in a short period that would normally accumulate over decades in middle-aged adults. Read more: https://www.insideprecisionmedicine.com/topics/oncology/childhood-chemotherapy-leaves-lasting-dna-damage-in-healthy-tissues/

Survival rates for childhood cancer now exceed 80%—but this also means more children are living with the long-term emotional and psychosocial impacts of cancer. Read more: https://medicalxpress.com/news/2026-09-children-cancer.html

But five-year survival answers only one question: whether a child lived through the immediate threat of cancer. It says much less about what happens at 25, 40, or 60—decades after the last dose of chemotherapy, a biologic, or the final radiation treatment. That question, largely invisible in headline survival statistics, is the subject of one of the longest-running and most influential research efforts in childhood cancer: the Childhood Cancer Survivor Study (CCSS). Read more

Survivors of pediatric cancers are at higher risk of getting age-related conditions, like heart disease and secondary cancers, at younger-than-average ages. Whether their immune systems also age more rapidly — and how this may contribute to the early onset of age-associated conditions — is an open question. Read more: https://www.fredhutch.org/en/news/center-news/2026/09/dhodapkar-immune-aging-survivorship-R01.html

Adult childhood cancer survivors treated with anthracyclines have elevated cardiometabolic risk, emphasizing the need for structured cardiac follow-up. Read more: https://www.oncologynurseadvisor.com/news/anthracyclines-cardiometabolic-risk-childhood-cancer-survivors-treatment/

Adult survivors of Hodgkin lymphoma had nearly twice the mortality of the general United States population, according to a population-based retrospective cohort study of 20,057 long-term survivors. Read more: https://www.emjreviews.com/en-us/amj/hematology/news/hodgkin-lymphoma-survivors-face-higher-long-term-mortality/